17-3571563-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000572705.2(TRPV1):c.2308G>A(p.Val770Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000577 in 1,611,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000572705.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPV1 | NM_080704.4 | c.2308G>A | p.Val770Ile | missense_variant | 16/17 | ENST00000572705.2 | NP_542435.2 | |
TRPV1 | NM_018727.5 | c.2308G>A | p.Val770Ile | missense_variant | 15/16 | NP_061197.4 | ||
TRPV1 | NM_080705.4 | c.2308G>A | p.Val770Ile | missense_variant | 15/16 | NP_542436.2 | ||
TRPV1 | NM_080706.3 | c.2308G>A | p.Val770Ile | missense_variant | 14/15 | NP_542437.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPV1 | ENST00000572705.2 | c.2308G>A | p.Val770Ile | missense_variant | 16/17 | 1 | NM_080704.4 | ENSP00000459962 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000980 AC: 24AN: 244942Hom.: 0 AF XY: 0.000113 AC XY: 15AN XY: 132810
GnomAD4 exome AF: 0.0000576 AC: 84AN: 1459280Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 39AN XY: 725608
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152222Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74356
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at